Description
OVERVIEWProduct overview
Mechano growth factor is a splice variant of IGF-1 expressed in muscle tissue following mechanical loading or damage. The peptide used in research corresponds to its distinct C-terminal region.
Pegylation is applied to extend the circulating profile of an otherwise very short-lived sequence in animal work.
Literature is limited and preclinical. Nothing here constitutes a treatment.
SUPPLY IN IRELANDPEG-MGF Ireland — supplied to research laboratories
Research groups across Ireland buy PEG-MGF from Kensington Laboratories as a lyophilised PEG-MGF peptide, released only against a batch-matched certificate of analysis. Every vial of high purity PEG-MGF is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering PEG-MGF in Ireland receive material with documented purity and identity.
Laboratory PEG-MGF is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning PEGMGF research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for PEG-MGF peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
PEG-MGF is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 2 mg per vial
- Peptide class: Pegylated synthetic peptide based on the mechano growth factor splice variant
- Also known as: Pegylated mechano growth factor, IGF-1Ec splice variant peptide
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
Mechano growth factor is a splice variant of IGF-1 expressed in muscle tissue following mechanical loading or damage. The peptide used in research corresponds to its distinct C-terminal region.
Pegylation is applied to extend the circulating profile of an otherwise very short-lived sequence in animal work.
Literature is limited and preclinical. Nothing here constitutes a treatment.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- Satellite cell activation and proliferation assays
- Muscle damage and repair models
- Splice variant specific signalling
- Pegylation and peptide half-life studies
Scientific context and proposed mechanisms
The C-terminal sequence is described as acting distinctly from mature IGF-1, with study authors focusing on satellite cell recruitment rather than classical IGF-1 receptor signalling.
Pegylation is a formulation strategy to slow clearance and is not itself a biological mechanism.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-PEGMGF-2406A
- Testing laboratory
- Colmaric Analyticals
- Date tested
- 9 June 2026
- Reported purity
- 99.23%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
The independent result for this batch is summarised above. Contact the laboratory team if you need the full report for this batch.
